Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause Cardiac failure congestive? 255 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 255 reports of Cardiac failure congestive have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.7% of all adverse event reports for ROSUVASTATIN.

255
Reports of Cardiac failure congestive with ROSUVASTATIN
0.7%
of all ROSUVASTATIN reports
11
Deaths
210
Hospitalizations

How Dangerous Is Cardiac failure congestive From ROSUVASTATIN?

Of the 255 reports, 11 (4.3%) resulted in death, 210 (82.4%) required hospitalization, and 11 (4.3%) were considered life-threatening.

Is Cardiac failure congestive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 255 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause Cardiac failure congestive?

ROSIGLITAZONE (15,085) METFORMIN\ROSIGLITAZONE (1,408) LENALIDOMIDE (1,373) AMBRISENTAN (1,359) SACUBITRIL\VALSARTAN (1,355) APIXABAN (1,144) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (1,129) AVANDIA (1,102) ADALIMUMAB (990) MACITENTAN (979)

Which ROSUVASTATIN Alternatives Have Lower Cardiac failure congestive Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All Cardiac failure congestive Reports All Drugs Causing Cardiac failure congestive ROSUVASTATIN Demographics